Risperidone-associated enuresis—a case report
Tóm tắt
Risperidone has been reported to be effective in treating both the positive and negative symptoms of schizophrenia, aggression, and behavioral disorders. While the metabolic side effect profile of this medication has been broadly studied, studies related to this medication’s bladder effects are relatively rare. We present a case of risperidone-induced enuresis in an adult male with schizophrenia that resolved upon discontinuation of the offending medication. We describe a case of a 32-year-old man with a primary psychotic disorder who developed debilitating enuresis secondary to taking risperidone. Enuresis resolved upon switching to Seroquel. Enuresis secondary to risperidone is not commonly discussed prior to initiation by the treating psychiatrist however can be debilitating. Discussing this potential side effect is critical to informed decision making on the patient’s part.
Tài liệu tham khảo
Kloosterboer SM, de Winter BCM, Reichart CG et al (2020) Risperidone plasma concentrations are associated with side effects and effectiveness in children and adolescents with autism spectrum disorder. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.14465
Madaan V, Bestha DP, Kolli V et al (2011) Clinical utility of the risperidone formulations in the management of schizophrenia. Neuropsychiatr Dis Treat 7:611–620. https://doi.org/10.2147/NDT.S14385
Harrison-Woolrych M, Skegg K, Ashton J et al (2011) Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study. Br J Psychiatry 199:140–144. https://doi.org/10.1192/bjp.bp.110.087478
Thiel J (2013) Second generation antipsychotics & nocturnal enuresis in children. Ment Heal Clin 2:370–374. https://doi.org/10.9740/mhc.n146896
Mergui J, Jaworowski S (2016) Risperidone-induced nocturnal enuresis successfully treated with reboxetine. Clin Neuropharmacol 39:152–153. https://doi.org/10.1097/WNF.0000000000000142
Bennett JA, Keck PEJ, Wallhausser LJ (1994) Desmopressin for risperidone-induced enuresis. Ann Clin Psychiatry Off J Am Acad Clin Psychiatr 6:139–140. https://doi.org/10.3109/10401239409148993
Rampino A, Marakhovskaia A, Soares-Silva T et al (2019) Antipsychotic drug responsiveness and dopamine receptor signaling; old players and new prospects. Front Psych 9:702
Monji A, Yanagimoto K, Yoshida I, Hashioka S (2004) SSRI-induced enuresis: a case report. J Clin Psychopharmacol 24:564–565
Took KJ, Buck BJ (1996) Enuresis with combined risperidone and SSRI use. J Am Acad Child Adolesc Psychiatry 35:840–841
Tonini M, Candura SM (1996) 5-HT4 receptor agonists and bladder disorders. Trends Pharmacol Sci 17:314–316
Rushton JL, Clark SJ, Freed GL (2000) Pediatrician and family physician prescription of selective serotonin reuptake inhibitors. Pediatrics 105:E82. https://doi.org/10.1542/peds.105.6.e82
Schwitalla TA, Patel RA, Catalano G, Nirmalani-Gandhy A (2019) Bupropion hydrochloride sustained release and diurnal enuresis: a previously unreported adverse effect. Clin Neuropharmacol 42:211–213. https://doi.org/10.1097/WNF.0000000000000364
Izci F, Iris Koc M, Bilici R et al (2015) Urinary incontinence during sleep associated with extended release form of bupropion HCI. Case Rep Psychiatry 2015:906294. https://doi.org/10.1155/2015/906294
Aggarwal A, Garg A, Jiloha RC (2009) Trihexyphenidyl (benzhexol) in clozapine-induced nocturnal enuresis and sialorrhea. Indian J Med Sci 63:470–471
Lee M-J, Kim C-E (2010) Use of aripiprazole in clozapine induced enuresis: report of two cases. J Korean Med Sci 25:333–335. https://doi.org/10.3346/jkms.2010.25.2.333
Fournier JP, Garfinkel BD, Bond A et al (1987) Pharmacological and behavioral management of enuresis. J Am Acad Child Adolesc Psychiatry 26:849–853. https://doi.org/10.1097/00004583-198726060-00009
Naguy A, Elsori DH, AlAwadhi DS, Alamiri B (2019) Add-on milnacipran boosts methylphenidate response in an adolescent with attention-deficit/hyperactivity disorder with comorbid anxiety and enuresis. Am J Ther 26:e730–e732. https://doi.org/10.1097/MJT.0000000000000884
Warner JP, Harvey CA, Barnes TR (1994) Clozapine and urinary incontinence. Int Clin Psychopharmacol 9:207–209. https://doi.org/10.1097/00004850-199409000-00010
Kusumi I, Boku S, Takahashi Y (2014) Psychopharmacology of atypical antipsychotic drugs : from the receptor binding profile to neuroprotection and neurogenesis, pp 243–258. https://doi.org/10.1111/pcn.12242
Michel MC, Peters SLM (2004) Role of serotonin and noradrenaline in stress urinary incontinence, pp 23–30
Barnes TRE, Drake MJ, Paton C (2012) Nocturnal enuresis with antipsychotic medication. Br J Psychiatry 200:7–9. https://doi.org/10.1192/bjp.bp.111.095737
Dhir A, Kulkarni SK (2008) Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors. Neurosci Lett 445:83–88. https://doi.org/10.1016/j.neulet.2008.08.074
Wishart DS, Feunang YD, Guo AC et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074–D1082. https://doi.org/10.1093/nar/gkx1037
Dean L (2017) Risperidone therapy and CYP2D6 genotype drug: risperidone, pp 1–8
Mendhekar DN, Andrade C (2010) Risperidone-related reversal of primary enuresis: an unusual case report. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry 11:514–515. https://doi.org/10.3109/15622970903369965